ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Aronson NE, Copeland NK, Magill AJ, 2020. Leishmania species. Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Cambridge, MA: Elsevier, 3321–3339.
-
2.
World Health Organization, 2023. Leishmaniasis. Available at: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis. Accessed March 22, 2023.
-
3.
Veloso de Carvalho LM et al., 2017. Sporotrichoid leishmaniasis: A cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil Livia. Rev Inst Med Trop São Paulo 59: e33.
-
4.
Gurel MS, Tekin B, Uzun S, 2020. Cutaneous leishmaniasis: A great imitator. Clin Dermatol 38: 140–151.
-
5.
Gaafar A, Fadl A, el Kadaro AY, el Hassan MM, Kemp M, Ismail AI, Morgos SA, el Hassan AM, 1994. Sporotrichoid cutaneous leishmaniasis due to Leishmania major of different zymodemes in the Sudan and Saudi Arabia: A comparative study. Trans R Soc Trop Med Hyg 88: 552–554.
-
6.
Kato H, Seki C, Kubo M, Gonzales-Cornejo L, Caceres AG, 2021. Natural infections of Pintomyia verrucarum and Pintomyia maranonensis by Leishmania (Viannia) peruviana in the eastern Andes of northern Peru. PLoS Negl Trop Dis 15: 1–13.
-
7.
Consigli J, Danielo C, Gallerano V, Papa M, Guidi A, 2006. Cutaneous leishmaniasis: Successful treatment with itraconazole. Int J Dermatol 45: 46–49.
-
8.
Centers for Disease Control and Prevention, 2024. Clinical Care of Leishmaniasis. Available at: https://www.cdc.gov/leishmaniasis/hcp/clinical-care/index.html. Accessed June 17, 2024.
-
9.
Bari AU, Rahman SB, 2008. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 74: 23–27.
-
10.
Ben Saïd M, Saghrouni F, Aoun YS-B, Ghariani N, Yaacoub A, Ach H, Denguezli M, Guizani I, Fathallah-Mili A, 2014. Sporotrichoid cutaneous leishmaniasis in central Tunisia: Epidemiological and clinical aspects. Claborn DM, ed. Leishmaniasis – Trends in Epidemiology, Diagnosis and Treatment. London, United Kingdom: InTech.
-
11.
Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V, 2009. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production. Hum Immunol 70: 383–390.
-
12.
Couppié P, Clyti E, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R, 2004. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: Case of a patient with 425 lesions. Am J Trop Med Hyg 71: 558–560.
-
13.
Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CEP, 2009. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol 31: 423–431.
-
14.
Hartley MA, Ronet C, Zangger H, Beverley SM, Fasel N, 2012. Leishmania RNA virus: When the host pays the toll. Front Cell Infect Microbiol 2: 99.
-
15.
Titus RG, Ribeiro JM, 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239: 1306–1308.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 4258 | 4258 | 94 |
| Full Text Views | 49 | 49 | 17 |
| PDF Downloads | 51 | 51 | 22 |
Case Report: A Case of Sporotrichoid Cutaneous Leishmaniasis Caused by Leishmania (Viannia) peruviana
Dai Akine
Dai Akine
Division of Infectious Diseases, Department of Medicine, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Ibaraki, Japan;
Division of Clinical Infectious Diseases, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan;
Search for other papers by Dai Akine in
Current site
Google Scholar
PubMed
Division of Clinical Infectious Diseases, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan;
Search for other papers by Dai Akine in
Current site
Google Scholar
PubMed
Teppei Sasahara
protozoa@jichi.ac.jp
Teppei Sasahara
Division of Clinical Infectious Diseases, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan;
Search for other papers by Teppei Sasahara in
Current site
Google Scholar
PubMed
Search for other papers by Teppei Sasahara in
Current site
Google Scholar
PubMed
Yuka Hirota
Yuka Hirota
Department of Pathology, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan;
Search for other papers by Yuka Hirota in
Current site
Google Scholar
PubMed
Search for other papers by Yuka Hirota in
Current site
Google Scholar
PubMed
Hirotomo Kato
Hirotomo Kato
Division of Medical Zoology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
Search for other papers by Hirotomo Kato in
Current site
Google Scholar
PubMed
Search for other papers by Hirotomo Kato in
Current site
Google Scholar
PubMed
ABSTRACT.
Leishmaniasis is caused by an obligate intracellular protozoa of the genus Leishmania. Its clinical manifestations include cutaneous, mucocutaneous, and visceral forms. Sporotrichoid cutaneous leishmaniasis (SCL) is an atypical and rare form of cutaneous leishmaniasis (CL) reported mainly in the Old World. This case report describes SCL in a Japanese man infected with Leishmania (Viannia) peruviana in Peru. His lesions occurred on both feet, with the left foot lesion being a simple CL that resolved spontaneously. However, the lesion on the right foot did not cure by itself; instead, it progressed centrally along the lymph nodes, eventually forming an SCL. Amastigotes were detected in both feet and genetically identified as L. (V.) peruviana. The lesions gradually resolved after treatment with intravenous liposomal amphotericin B. Here, we report the first case of SCL caused by L. (V.) peruviana.
Author Notes
Financial support: This study was financially supported by the
Disclosures. The authors explicitly state that there are no conflicts of interest related to this article. Their institution does not require approval from the institutional ethics committee for case reports. Informed consent was obtained from the patient for this case report.
Current contact information: Dai Akine, Division of Infectious Diseases, Department of Medicine, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Ibaraki), and Division of Clinical Infectious Diseases, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, E-mail: m00001da@jichi.ac.jp. Teppei Sasahara, Division of Clinical Infectious Diseases, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, E-mail: protozoa@jichi.ac.jp. Yuka Hirota, Department of Pathology, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, E-mail: yhirota@jichi.ac.jp. Hirotomo Kato, Division of Medical Zoology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan, E-mail: hirok@jichi.ac.jp.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Aronson NE, Copeland NK, Magill AJ, 2020. Leishmania species. Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Cambridge, MA: Elsevier, 3321–3339.
-
2.
World Health Organization, 2023. Leishmaniasis. Available at: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis. Accessed March 22, 2023.
-
3.
Veloso de Carvalho LM et al., 2017. Sporotrichoid leishmaniasis: A cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil Livia. Rev Inst Med Trop São Paulo 59: e33.
-
4.
Gurel MS, Tekin B, Uzun S, 2020. Cutaneous leishmaniasis: A great imitator. Clin Dermatol 38: 140–151.
-
5.
Gaafar A, Fadl A, el Kadaro AY, el Hassan MM, Kemp M, Ismail AI, Morgos SA, el Hassan AM, 1994. Sporotrichoid cutaneous leishmaniasis due to Leishmania major of different zymodemes in the Sudan and Saudi Arabia: A comparative study. Trans R Soc Trop Med Hyg 88: 552–554.
-
6.
Kato H, Seki C, Kubo M, Gonzales-Cornejo L, Caceres AG, 2021. Natural infections of Pintomyia verrucarum and Pintomyia maranonensis by Leishmania (Viannia) peruviana in the eastern Andes of northern Peru. PLoS Negl Trop Dis 15: 1–13.
-
7.
Consigli J, Danielo C, Gallerano V, Papa M, Guidi A, 2006. Cutaneous leishmaniasis: Successful treatment with itraconazole. Int J Dermatol 45: 46–49.
-
8.
Centers for Disease Control and Prevention, 2024. Clinical Care of Leishmaniasis. Available at: https://www.cdc.gov/leishmaniasis/hcp/clinical-care/index.html. Accessed June 17, 2024.
-
9.
Bari AU, Rahman SB, 2008. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 74: 23–27.
-
10.
Ben Saïd M, Saghrouni F, Aoun YS-B, Ghariani N, Yaacoub A, Ach H, Denguezli M, Guizani I, Fathallah-Mili A, 2014. Sporotrichoid cutaneous leishmaniasis in central Tunisia: Epidemiological and clinical aspects. Claborn DM, ed. Leishmaniasis – Trends in Epidemiology, Diagnosis and Treatment. London, United Kingdom: InTech.
-
11.
Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, Dessein A, Rodrigues V, 2009. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production. Hum Immunol 70: 383–390.
-
12.
Couppié P, Clyti E, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R, 2004. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: Case of a patient with 425 lesions. Am J Trop Med Hyg 71: 558–560.
-
13.
Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CEP, 2009. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol 31: 423–431.
-
14.
Hartley MA, Ronet C, Zangger H, Beverley SM, Fasel N, 2012. Leishmania RNA virus: When the host pays the toll. Front Cell Infect Microbiol 2: 99.
-
15.
Titus RG, Ribeiro JM, 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239: 1306–1308.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 4258 | 4258 | 94 |
| Full Text Views | 49 | 49 | 17 |
| PDF Downloads | 51 | 51 | 22 |